Category: Health Care
Trump rejects doctors’ advice to take less aspirin: ‘I want nice, thin blood’
President Trump said in new interview regarding his health that he has rejected his doctors’ advice to take less aspirin for cardiac prevention because he has been taking it for more than two decades and is a “little superstitious.” “They say aspirin is good for thinning out the blood, and I don’t want thick blood…
What action has Trump administration taken in Minnesota since viral fraud video?
The Trump administration has ramped up scrutiny of Minnesota’s social services programs amid allegations of fraud. Independent journalist Nick Shirley released a video detailing his investigation into the issue on Friday, sparking a renewed interest into the allegations. The Department of Justice (DOJ) has charged 98 people in connection with its sweeping probe into the…
FDA approves oral version of Wegovy
The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight loss pill, the first such pill approved for use. Novo Nordisk said in a Tuesday release that the GLP-1 pill is intended for once-daily use to “reduce excess body weight and maintain weight reduction long-term and to reduce the…
Senate stares down fraught health care battle with ObamaCare subsidies set to expire
Senate negotiators are set for a high-wire act on health care in the coming weeks after leaving Washington for the holidays without a resolution on the expiring enhanced subsidies, with lawmakers increasingly shifting into campaign mode as the calendar flips to the new year. The chamber has been consumed for months by a fight over…
Jeffries says House ‘will pass’ ObamaCare subsidies extension ‘with a bipartisan majority’
House Minority Leader Hakeem Jeffries (D-N.Y.) predicted Sunday that an extension of subsidies offered under the Affordable Care Act (ACA) will pass the House with backing from both sides of the aisle. “House Democrats are going to continue to fight to get this extension through the Congress on our side. It will pass with a…
Doctors warn of ‘super flu’ variant circulating in hot spots across the country
Ahead of the holiday tourist rush, city health officials in New York City reported nearly 14,000 flu cases in the first week of December.
Your lawmakers’ big drug-price stunt could strand millions without meds
State lawmakers, desperate to address America’s sky-high drug prices, have turned their fire on pharmacy benefit managers. Their chosen tools — outright bans in Arkansas and suffocating regulations in Indiana — will not rein in drug costs. They will close pharmacies, however. And disabled Americans will feel the pain first and worst.
For millions of people living with disabilities or chronic illnesses, the neighborhood pharmacy isn’t just a place to pick up a prescription. It is a medical anchor — often the only dependable access point in a fragmented health care system.
Policy leaders must hold three truths at once: Drug prices are too high, access is too fragile, and for disabled Americans, both problems collide.
When states make it harder for pharmacies to operate, they aren’t tightening consumer protections. They are tightening a noose around the patients they claim to protect.
Proximity is key
Healthy, mobile adults can switch pharmacies with mild frustration. Disabled Americans can’t. They rely on stable, nearby pharmacy relationships to manage complex regimens, limited transportation, and conditions that make in-person care indispensable.
A person with epilepsy juggling multiple medications cannot suddenly travel to a pharmacy two towns over. A disabled veteran with hearing loss cannot sit on hold for an hour to fix a refill problem. A parent caring for a child with developmental disabilities needs a pharmacist who knows her family and can explain changes — especially potential interactions — face to face.
For disabled patients, proximity isn’t convenience. It is continuity, safety, and sometimes survival.
Long before I served as commissioner for the Administration on Disability at Health and Human Services, I was a teacher who learned that real service depends on presence. You must know the person in front of you. The same holds true in every field: the banker who helps you fix a missed payment, the pastor who walks beside his congregation. Their influence comes from relationship.
Pharmacists are no different. They cannot be replaced with apps, compliance checklists, or centralized call centers. Their work depends on knowing their patients — and being close enough to serve them.
What happens when pharmacies disappear?
Imagine telling a cancer patient he now needs to drive 20 miles for treatment because a state ban forced his local pharmacy to close.
Imagine telling a parent managing her child’s seizure medications that she must start over with a new pharmacy because the compliance burden became too much to stay open.
Imagine telling a stroke survivor who no longer drives that “it’s only a few minutes farther.” For many disabled Americans, a few minutes farther means losing independence — or tipping into crisis.
Pharmacies provide far more than prescriptions. They monitor complex drug regimens and catch dangerous interactions. They manage refills when cognitive disabilities make self-management difficult. They offer immediate, walk-in guidance when something feels wrong. They coordinate with doctors on sudden changes. And maybe most importantly, they provide calm, in-person clarity that no software platform can match.
Lawmakers say they want to help, but they are ignoring what disabled Americans need most: stable, nearby pharmacies that can remain open.
RELATED: The maligned and misunderstood player that Big Pharma wants gone
Oleg Elkov via iStock/Getty Images
Access is a crisis
Drug prices in America are too high. Disabled Americans feel that burden more than anyone because they use more medications, more often, and for longer durations. Many rely on mail-order programs and already face delays and shortages.
So yes, policymakers should push for lower prices. They should demand transparency from pharmacy benefit managers so patients know what they are paying. They should pressure pharmaceutical companies to create pricing structures that serve consumers instead of shareholders.
But none of that will matter if the pharmacies disabled Americans depend on are regulated out of business.
Policy leaders must hold three truths at once: Drug prices are too high, access is too fragile, and for disabled Americans, both problems collide.
You cannot help vulnerable people by making their closest health care providers harder to reach. If states want to protect patients, they should create a regulatory environment where pharmacies can survive — and where the communities that depend on them can too.
